Hong Kong
Xiaomi reportedly lowers valuation after delaying Mainland offering
Xiaomi reportedly lowers valuation after delaying Mainland offering
The likely valuation of the smartphone maker is now between US$55b to US$70b.
Unemployment flat at 2.8% in March-May
This translates to 112,300 unemployed persons.
Mobile to snap third of internet ad revenues by 2022
The segment is expected to bring in US$285m in four years time.
Banks to hike prime rates by end-June
Tighter liquidity from mega IPOs will leave lenders with no other option.
HKIA passenger volume hits 6.04m in May
The number of visitors from Japan and the Mainland surged.
Xiaomi to postpone Mainland share offering
The company may be aiming to complete its Hong Kong listing first.
Mainland lender Jiangxi Bank eyes $7.79b Hong Kong IPO
Citic Guoan Group and Dianrong are cornerstone investors.
Government launches Green Bond Grant Scheme
It subsidises green bond issuers in obtaining certification.
Hong Kong is the second largest offshore wealth center
It trails behind Switzerland after managing US$1.1t in offshore wealth.
Cyberattacks could cost Hong Kong nearly $250b annually
Mobile payment apps are expected to be the next high-value target.
Mainland online lender Lufax guns for US$2b fresh funding amidst IPO delay
It was originally planning to debut at the first half of 2018.
US biotech firm seeking larger valuations rush to Hong Kong
Sorrento Therapeutics is one such firm hoping to cash in on the trend.
Manufacturing industrial production index up 1.1% in Q1
Output volume from food, beverages and tobacco industry rose 2.4%.
Swire Properties to reportedly sell Cityplaza Three and Four for $14b
The buyer is Hengli Investment Holding Group.
US tightening buoys banking profitability
Funding costs are expected to stay low, boosting NIMs.
IPOs surge 33% to US$725m in H1 2018
A total of 53 companies went public in the first half of the year.
Chinese medical tourists are exhausting local HPV cancer drug supply
An estimated 2m Chinese have come to Hong Kong to receive the shot in past two years.
Commentary
Hong Kong: At the forefront of digitalisation and evolving international disputes
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Capital repatriation isn't a retreat — it’s Hong Kong’s regulatory graduation
Hong Kong should build the Asia–Latin America investment corridor